Institutional shares held 781 Million
15.4M calls
11.5M puts
Total value of holdings $499B
$9.86B calls
$7.37B puts
Market Cap $608B
950,174,976 Shares Out.
Institutional ownership 82.15%
# of Institutions 4,426


Latest Institutional Activity in LLY

Top Purchases

Q2 2025
Laurel Wealth Advisors LLC Shares Held: 11.6M ($7.39B)
Q2 2025
Norges Bank Shares Held: 11.3M ($7.24B)
Q2 2025
Capital Research Global Investors Shares Held: 20.8M ($13.3B)
Q2 2025
Wellington Management Group LLP Shares Held: 14M ($8.95B)
Q2 2025
Vanguard Group Inc Shares Held: 80.4M ($51.4B)

Top Sells

Q2 2025
Pnc Financial Services Group, Inc. Shares Held: 51.3M ($32.8B)
Q2 2025
Primecap Management CO Shares Held: 12.2M ($7.77B)
Q2 2025
Price T Rowe Associates Inc Shares Held: 16.8M ($10.8B)
Q2 2025
Gqg Partners LLC Shares Held: 273K ($174M)
Q2 2025
Amundi Shares Held: 3.56M ($2.28B)

About LLY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Insider Transactions at LLY

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
210K Shares
From 41 Insiders
Grant, award, or other acquisition 133K shares
Open market or private purchase 6.27K shares
Exercise of conversion of derivative security 70.1K shares
Sell / Disposition
1.29M Shares
From 21 Insiders
Open market or private sale 1.22M shares
Payment of exercise price or tax liability 31.3K shares
Bona fide gift 42.2K shares

Track Institutional and Insider Activities on LLY

Follow ELI LILLY & Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LLY shares.

Notify only if

Insider Trading

Get notified when an Eli Lilly & CO insider buys or sells LLY shares.

Notify only if

News

Receive news related to ELI LILLY & Co

Track Activities on LLY